Bard Financial Services’s BioLife Solutions BLFS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
$3.92M Hold
153,475
0.43% 61
2025
Q2
$3.31M Hold
153,475
0.39% 64
2025
Q1
$3.51M Hold
153,475
0.43% 59
2024
Q4
$3.98M Hold
153,475
0.48% 54
2024
Q3
$3.84M Sell
153,475
-36,825
-19% -$870K 0.45% 54
2024
Q2
$4.08M Buy
190,300
+56,665
+42% +$1.1M 0.42% 57
2024
Q1
$2.48M Hold
133,635
0.26% 80
2023
Q4
$2.17M Hold
133,635
0.24% 87
2023
Q3
$1.85M Buy
133,635
+8,635
+7% +$136K 0.23% 87
2023
Q2
$2.76M Hold
125,000
0.21% 98
2023
Q1
$2.72M Hold
125,000
0.22% 94
2022
Q4
$2.27M Hold
125,000
0.19% 107
2022
Q3
$2.84M Sell
125,000
-48,190
-28% -$1.03M 0.27% 89
2022
Q2
$2.39M Hold
173,190
0.22% 97
2022
Q1
$3.94M Hold
173,190
0.32% 78
2021
Q4
$6.46M Hold
173,190
0.52% 53
2021
Q3
$7.33M Buy
+173,190
New +$8.34M 0.65% 46

Other funds holding BLFS

Bard Financial Services's BLFS Position: Q3 2025 in Review

Bard Financial Services held its BioLife Solutions (BLFS) position steady in Q3 2025 at 153,475 shares worth $3.92M. The position accounts for 0.43% of the portfolio, ranked #61.

Bard Financial Services first reported a position in BLFS in Q3 2021 and has held it in 17 quarters since. The position peaked at $7.33M in Q3 2021. 192 funds tracked by Wall St. Rank hold BLFS as of Q3 2025.

  • Bard Financial Services held 153,475 shares of BioLife Solutions worth $3.92M as of Q3 2025.
  • Bard Financial Services left its BioLife Solutions share count unchanged in Q3 2025.
  • BioLife Solutions made up 0.43% of Bard Financial Services's portfolio in Q3 2025, its #61 holding.
  • Bard Financial Services first reported a position in BioLife Solutions in Q3 2021 and has held it in 17 quarters since.
  • Bard Financial Services's BioLife Solutions position peaked at $7.33M in Q3 2021.
  • 192 funds tracked by Wall St. Rank held BioLife Solutions as of Q3 2025.

Based on Bard Financial Services's 13F filing for Q3 2025, filed 17 Oct 2025.